Author:
Hawkes Jason E.,Duffin Kristina Callis
Publisher
Springer International Publishing
Reference67 articles.
1. Norris DA. Mechanisms of action of topical therapies and the rationale for combination therapy. J Am Acad Dermatol. 2005;53:S17–25.
2. Cornell RC, Stoughton RB. Correlation of the vasoconstriction assay and clinical activity in psoriasis. Arch Dermatol. 1985;121:63–7.
3. Goldberg B, Hartdegen R, Presbury D, et al. A double-blind, multicenter comparison of 0.05 % halobetasol propionate ointment and 0.05 % clobetasol propionate ointment in patients with chronic, localized plaque psoriasis. J Am Acad Dermatol. 1991;25:1145–8.
4. Beutner K, Chakrabarty A, Lemke S, et al. An intra-individual randomized safety and efficacy comparison of clobetasol propionate 0.05 % spray and its vehicle in the treatment of plaque psoriasis. J Drugs Dermatol JDD. 2006;5:357–60.
5. Sofen H, Hudson CP, Cook-Bolden FE, et al. Clobetasol propionate 0.05 % spray for the management of moderate-to-severe plaque psoriasis of the scalp: results from a randomized controlled trial. J Drugs Dermatol JDD. 2011;10:885–92.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Topical treatment of psoriasis;Dermatologie pro praxi;2018-12-01